We are live on
!
Find out more
KAM
Kazazian Asset Management Portfolio holdings
AUM
$111M
1-Year Est. Return
29.02%
This Fund
S&P 500
This Quarter
Est. Return
+4.5%
1 Year Est. Return
+29.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$13.7M
(+14%)
Cap. Flow
+$11.8M
Cap. Flow
% of AUM
10.79%
Top 10 Holdings %
Top 10 Hldgs %
52.61%
Holding
94
New
9
Increased
24
Reduced
52
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.81M |
| 2 |
DigitalBridge
DBRG
|
+$2.26M |
| 3 |
Biogen
BIIB
|
+$2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$1.65M |
| 5 |
Global X MLP ETF
MLPA
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$2.11M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11M |
| 3 |
Intel
INTC
|
+$1.08M |
| 4 |
Nektar Therapeutics
NKTR
|
+$627K |
| 5 |
Chipotle Mexican Grill
CMG
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.91% |
| 2 | Miscellaneous | 25.64% |
| 3 | Financials | 12.01% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Communication Services | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EIGI
26
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $1.09M | 1% |
109,908
-6,439
| -6% | -$55.1K |
|
27
State Street Financial Select Sector SPDR ETF
XLF
$54.5B
| $1.06M | 0.98% |
+40,000
| New | +$1.1M |
|
28
Aurinia Pharmaceuticals
AUPH
$2.14B
| $959K | 0.88% |
170,356
+14,230
| +9% | +$79.4K |
|
29
Visa
V
$701B
| $927K | 0.85% |
+7,000
| New | +$901K |
|
30
iShares Biotechnology ETF
IBB
$10.4B
| $824K | 0.76% |
7,500
| – | – |
|
|
SPPI
31
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $788K | 0.72% |
37,590
+5,064
| +16% | +$93.8K |
|
32
Oracle
ORCL
$417B
| $759K | 0.7% |
17,216
-944
| -5% | -$43.5K |
|
|
PTLA
33
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $733K | 0.67% |
19,419
+2,509
| +15% | +$96K |
|
34
Merck
MRK
$357B
| $702K | 0.64% |
12,114
-454
| -4% | -$25.6K |
|
|
ZGNX
35
DELISTED
Zogenix, Inc.
ZGNX
| $692K | 0.63% |
15,664
-604
| -4% | -$24.9K |
|
36
Targa Resources
TRGP
$62.2B
| $690K | 0.63% |
13,944
-765
| -5% | -$36.4K |
|
|
BLUE
37
DELISTED
bluebird bio
BLUE
| $688K | 0.63% |
339
-13
| -4% | -$29.6K |
|
|
DO
38
DELISTED
Diamond Offshore Drilling
DO
| $615K | 0.56% |
29,480
-1,622
| -5% | -$30.2K |
|
39
Abbott
ABT
$178B
| $588K | 0.54% |
9,640
-1,048
| -10% | -$63.5K |
|
|
CLLS
40
Cellectis
CLLS
$184M
| $532K | 0.49% |
18,792
+5,784
| +44% | +$172K |
|
|
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $525K | 0.48% |
+3,759
| New | +$534K |
|
42
Puma Biotechnology
PBYI
$471M
| $519K | 0.48% |
8,771
+1,614
| +23% | +$93.5K |
|
|
GBT
43
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $510K | 0.47% |
11,278
-433
| -4% | -$19.7K |
|
44
GSK
GSK
$100B
| $505K | 0.46% |
10,024
-385
| -4% | -$19.4K |
|
45
Incyte
INCY
$24.8B
| $504K | 0.46% |
7,520
+1,664
| +28% | +$114K |
|
46
Ultragenyx Pharmaceutical
RARE
$1.34B
| $482K | 0.44% |
6,268
-240
| -4% | -$15.5K |
|
|
NBL
47
DELISTED
Noble Energy, Inc.
NBL
| $454K | 0.42% |
12,864
-708
| -5% | -$24.1K |
|
|
NETI
48
DELISTED
Eneti Inc.
NETI
| $452K | 0.41% |
6,857
-673
| -9% | -$46.3K |
|
|
TSRO
49
DELISTED
TESARO, Inc.
TSRO
| $446K | 0.41% |
10,024
-384
| -4% | -$18.7K |
|
|
LJPC
50
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $436K | 0.4% |
14,943
-573
| -4% | -$17.7K |
|
Similar funds
FF
GH
VR
WCBA
CCM
LA
MASM
PFG
Kazazian Asset Management's Q2 2018 Portfolio in Review
As of Q2 2018, Kazazian Asset Management held 94 positions worth $109M, up 14% from $95.4M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Kazazian Asset Management deployed $11.8M of net new capital in Q2 2018, opening 9 new positions and adding to 24 existing holdings. Its largest new stake was Walt Disney: 12,000 shares worth $1.26M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11M trimmed.
- Kazazian Asset Management's largest Q2 2018 buy was Walt Disney: 12,000 shares worth $1.26M.
- Kazazian Asset Management added most to iShares MSCI Emerging Markets ETF in Q2 2018, an estimated $2.81M increase.
- Kazazian Asset Management's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11M.
- Kazazian Asset Management fully exited State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q2 2018, selling an estimated $2.11M.
- Kazazian Asset Management's ten largest holdings make up 53% of its $109M portfolio in Q2 2018.
- Kazazian Asset Management opened 9 new positions and closed 6 in Q2 2018.
- Kazazian Asset Management's portfolio value rose 14% quarter-over-quarter to $109M.
Based on Kazazian Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.